Kala Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 05/15/2025 | 1.20 M | $6.89 M | 0.00% | 18.94% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 603.03 K | $3.46 M | 0.00% | 9.50% |
| SR ONE CAPITAL MANAGEMENT, LP | 05/13/2025 | 598.94 K | $3.43 M | 0.00% | 9.44% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 298.96 K | $1.71 M | 35.66% | 4.71% |
| PERCEPTIVE ADVISORS LLC | 05/15/2025 | 277.61 K | $1.59 M | 100.00% | 4.37% |
| WOODLINE PARTNERS LP | 05/15/2025 | 258.77 K | $1.48 M | 100.00% | 4.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2025 | 246.08 K | $1.41 M | 6.50% | 3.88% |
| AIGH CAPITAL MANAGEMENT LLC | 05/06/2025 | 196.35 K | $1.13 M | 61.87% | 3.09% |
| UBS OCONNOR LLC | 05/15/2025 | 170.92 K | $979.35 K | -4.48% | 2.69% |
| VANGUARD GROUP INC | 05/09/2025 | 152.78 K | $875.40 K | 185.19% | 2.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 54.83 K | $314.24 K | 15.09% | 0.86% |
| READYSTATE ASSET MANAGEMENT LP | 05/06/2025 | 42.46 K | $243.29 K | 100.00% | 0.67% |
| BLACKROCK, INC. | 05/02/2025 | 21.36 K | $122.37 K | 0.00% | 0.34% |
| NORTHERN TRUST CORP | 05/13/2025 | 10.40 K | $59.59 K | 100.00% | 0.16% |
| UBS GROUP AG | 05/13/2025 | 3.41 K | $19.56 K | 8.21% | 0.05% |
| COVESTOR LTD | 05/12/2025 | 1.14 K | $7.00 K | 17.65% | 0.02% |
| MORGAN STANLEY | 05/15/2025 | 972 | $5.57 K | 0.00% | 0.02% |
| MAI CAPITAL MANAGEMENT | 05/15/2025 | 300 | $1.72 K | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 221 | $1.27 K | -68.96% | 0.00% |
| CHEVIOT VALUE MANAGEMENT, LLC | 05/09/2025 | 153 | $555 | 100.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/13/2025 | 120 | $688 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 98 | $562 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 60 | $344 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 49 | $281 | 32.43% | 0.00% |
| 05/16/2025 | 25 | $144 | 150.00% | 0.00% | |
| 05/02/2025 | 8 | $46 | 0.00% | 0.00% | |
| 05/14/2025 | 8 | $46 | 100.00% | 0.00% | |
| 05/12/2025 | 1 | $139 | -95.00% | 0.00% | |
| PARALLEL ADVISORS, LLC | 04/08/2025 | 1 | $6 | 0.00% | 0.00% |
| CITIGROUP INC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| CWM, LLC | 05/01/2025 | 0 | $0 | -100.00% | 0.00% |
| COMPAGNIE LOMBARD ODIER SCMA | 04/16/2025 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kala Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Kala Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 1.2 M
Cormorant Asset Management, LP: 603,027
SR ONE CAPITAL MANAGEMENT, LP: 598,940
ADAR1 Capital Management, LLC: 298,955
PERCEPTIVE ADVISORS LLC: 277,610
Woodline Partners LP: 258,766
65.25% of Kala Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.92 M shares in the last 24 months. This purchase volume represents approximately $24.94 M in transactions.